Publications

Journal Article Ppublish 6 citations
Electronic publication date
August 26, 2024

View on Pubmed.gov 39184370 | View on doi.org 10.1002/pgr2.22

Proteoglycans of basement membranes: Crucial controllers of angiogenesis, neurogenesis, and autophagy.

Search for publications in this journal Proteoglycan Res

Abstract

Anti-angiogenic therapy is an established method for the treatment of several cancers and vascular-related diseases. Most of the agents employed target the vascular endothelial growth factor A, the major cytokine stimulating angiogenesis. However, the efficacy of these treatments is limited by the onset of drug resistance. Therefore, it is of fundamental importance to better understand the mechanisms that regulate angiogenesis and the microenvironmental cues that play significant role and influence patient treatment and outcome. In this context, here we review the importance of the three basement membrane heparan sulfate proteoglycans (HSPGs), namely perlecan, agrin and collagen XVIII. These HSPGs are abundantly expressed in the vasculature and, due to their complex molecular architecture, they interact with multiple endothelial cell receptors, deeply affecting their function. Under normal conditions, these proteoglycans exert pro-angiogenic functions. However, in pathological conditions such as cancer and inflammation, extracellular matrix remodeling leads to the degradation of these large precursor molecules and the liberation of bioactive processed fragments displaying potent angiostatic activity. These unexpected functions have been demonstrated for the C-terminal fragments of perlecan and collagen XVIII, endorepellin and endostatin. These bioactive fragments can also induce autophagy in vascular endothelial cells which contributes to angiostasis. Overall, basement membrane proteoglycans deeply affect angiogenesis counterbalancing pro-angiogenic signals during tumor progression, and represent possible means to develop new prognostic biomarkers and novel therapeutic approaches for the treatment of solid tumors.

References

J Biol Chem. 2000 Mar 10;275(10):7095-100

Matrix Biol. 2019 Jan;75-76:1-11

Oncogene. 2018 Jun;37(25):3399-3414

Gene. 2022 Mar 20;815:146137

Cited by 6 citations (total)

Journal Article Review

Soluble Proteoglycans and Proteoglycan Fragments as Biomarkers of Pathological Extracellular Matrix Remodeling.

Electronic publication date November 27, 2024

Search for publications in this journal Proteoglycan Res

Marsioleda Kemberi [...] Salvatore Santamaria et al.

Proteoglycans and their proteolytic fragments diffuse into biological fluids such as plasma, serum, urine, or synovial fluid, where they can...

Journal Article Review

Proteoglycans are protagonists in autophagy, lymphangiogenesis, and neurodegenerative diseases.

Electronic publication date July 12, 2025

Search for publications in this journal Trends Cell Biol

Gabriel J Pascal [...] Renato V Iozzo et al.

Proteoglycans (PGs) are specialized cell-surface and secreted proteins teeming with bioactivity. They have been the subject of fascinating research on...

Conflict of interest statement

CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest.

MeSH

Specialties